Contact: Matthew Titcomb; Last date for abstract submission: Not available; GIIDS focuses exclusively on overcoming translational drug development challenges to achieve more clinically safe and efficacious therapeutics for Inflammatory Bowel Disease. Tickets https://go.evvnt.com/392494-2?pid=80